Diabytes
Aurobindo Pharma climbs after USFDA nod for OTC drug
Shares of Aurobindo Pharma surged over 2 percent today after the firm got final approval from USFDA to manufacture and market its generic Naproxen Sodium tablets used for treatment of osteoporosis.
Trending Photos
5- 10
- 10
- 13
Mumbai: Shares of Aurobindo Pharma surged over 2 percent today after the firm got final approval from USFDA to manufacture and market its generic Naproxen Sodium tablets used for treatment of osteoporosis.
The stock soared 2.31 percent to Rs 738 on BSE.
On NSE too, shares of the company climbed 2.31 percent to Rs 737.95.
"The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Naproxen Sodium tablets USP, 220 mg," Aurobindo Pharma had said in a BSE filing on Saturday.
"The product is expected to be launched in Q1 of 2016-17," it had said.
 "DNA: Is there plastic in your blood too?")
 "DNA: Threat of nuclear war?")
 "DNA: How could Iran-Israel war impact India?")
 "DNA: How to identify deepfake videos?")
 "DNA: Analysis of first phase voting of Lok Sabha Elections")
 "DNA: PM Modi watches Surya Tilak of Shri Ram Lalla")
 "DNA: Inside story of 29 Naxalites' encounter")
 "DNA test of 'religious thinking' on UPSC list")
 "DNA: Did cloud seeding drown Dubai?")
 "DNA: Is Israel going to bring a big storm?")
